A New Line of Defense in Blood Cancer: Natural Killer Cell Therapy
Natural killer cell therapy is making strides in blood cancer research, but there’s still much more to learn.
Read More
When Patients with the Earliest Form of Breast Cancer May Be Able to Skip Surgery
Can mastectomy or lumpectomy be avoided in women with ductal carcinoma in situ?
Immunotherapy Just After Chemo May Allow Some Patients with Bladder Cancer to Maintain Health Benefits
Patients with advanced or metastatic bladder cancer, after responding to initial treatment with chemotherapy, may preserve their health improvements by starting immunotherapy immediately.
Coming Clean: Protecting Yourself From Bacteria on Endoscopes
Bacteria lingering on endoscopes can lead to drug-resistant infections. Before getting scoped, patients should ask how they will be protected.
Beyond the Lungs
New therapies offer options for patients with non-small cell lung cancer whose disease has spread to the brain.
Hormones Gone Mad in a Rare Type of Ovarian Cancer
A rare type of ovarian tumor can raise testosterone levels, causing women to develop male characteristics. The main treatments: surgery and chemotherapy.
Ovarian Cancer's New Identity: A Chronic Disease
Women with this disease are living longer, despite common recurrence.
Read Between the Lines: Understanding Clinical Studies
Understanding clinical study results can be difficult. Follow these tips to navigate the language and organization of cancer research papers.
A Breath of Fresh Air for Advanced Lung Cancer
Immunotherapy and stereotactic radiation are making a difference for some patients with advanced lung cancer.
A State of Flux for Kidney Cancer
Targeted drugs are controversial in early-stage kidney cancer, but play a more important role in treating advanced disease.
